A smart spacer to help children with uncontrolled asthma use their inhalers
Tests a smart spacer for inhaler technique in children with uncontrolled asthma.
Plain-language title generated from the registry record
Registry title: Using a Digital Spacer for Inhaler Technique Education in Pediatric Asthma
Key facts
- Where
- Groningen, NetherlandsSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 18 years old?
Source: NCT07803042, who can take part
Where in Netherlands
- UMC GroningenGroningen, NetherlandsNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Medical Center Groningen
- Trial code
- NCT07803042
- Record updated
- 3 September 2026
- Original description
This pilot study evaluates the feasibility, usability, and potential effect of the aflo™ Smart Spacer platform in children aged 6-18 with uncontrolled asthma using pMDIs and spacers. The study investigates changes in inhaler technique, asthma control, and lung function following 3 months of daily use of the CE-marked aflo™ device.Read full original descriptionShow less
Using the Aflo™ Digital Smart Spacer Platform to Improve Inhaler Technique in Children With Uncontrolled Asthma: A Prospective Pilot Study - INSPIRE-KIDS (INhaler SPacer Improvement & Real-time Education - KIDS)
This pilot study evaluates the feasibility, usability, and potential effect of the aflo™ Smart Spacer platform in children aged 6-18 with uncontrolled asthma using pMDIs and spacers. The study investigates changes in inhaler technique, asthma control, and lung function following 3 months of daily use of the CE-marked aflo™ device.
Inclusion: Age 6-18 years; Physician-diagnosed asthma; Using ICS ± LABA ± LAMA ± SABA via pMDI and spacer suitable for aflo™; Uncontrolled asthma (ACT <19 and/or recent exacerbation and/or suspected nonadherence/poor technique); Access to an Apple or Android smartphone (OS ≥ 4.3); Willing and able to give assent/consent (parents/guardians for minors).
Exclusion: Chronic lung disease other than asthma; Significant cardiac disease; Not able to understand Dutch sufficiently; No access to stable mobile internet.